Tizanidine Tablet
Product Images NDC 55111-180

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 55111-180). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container1 (Container1)

FDA Label Image

Container2 (Container2)

FDA Label Image

Container3 (Container3)

FDA Label Image

Container4 (Container4)

FDA Label Image

Fig1 (Fig1)

This document provides information on plasma Tzanidine concentration measured in ng/mL at different hours from dosing in individuals who took either 2x 4mg Tzanidine tablets with food (group A), 2x4mg Tzanidine tablets without food (group B), 2x4mg Tzanidine capsules with food (group G), or 2x4mg Tzanidine capsules without food (group D). There is no additional information available on this document.*

FDA Label Image

Fig2 (Fig2)

FDA Label Image

Fig3 (Fig3)

This appears to be a study report focused on the effects of a medication called Zanidine on the Ashworth Score. The text mentions improvement in Ashworth Score and gives information about the mean dosage of the medication. The study is observed for a period of 7 weeks and the last observation is noted as Garred Forward.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.